Alternating magnetic fields (AMF) and linezolid reduce Staphylococcus aureus biofilm in a large animal implant model

Isuru A Somawardana1, Bibin Prasad2, Walker Kay3

  • 1Texas A&M School of Engineering Medicine, Houston, TX 77030, USA; Solenic Medical, Inc., Addison, TX 75001, USA.

The Journal of Infection
|September 15, 2024
PubMed
Abstract

Insights

Combining alternating magnetic fields (AMF) with antibiotics significantly reduced Staphylococcus aureus biofilm on metal implants in a large animal model. This novel approach offers a promising non-invasive treatment for prosthetic joint infections.

Area of Science:

  • Biomedical Engineering
  • Infectious Diseases
  • Materials Science

Background:

  • Prosthetic joint infections are a significant clinical challenge, often caused by Staphylococcus aureus biofilms on metal implants.
  • Antibiotic resistance and biofilm formation necessitate innovative treatment strategies.

Purpose of the Study:

  • To evaluate the efficacy of alternating magnetic fields (AMF) combined with linezolid in reducing Staphylococcus aureus biofilm on metal implants.
  • To compare the combination therapy against antibiotic-only treatment in a large animal model.

Main Methods:

  • Metal plates (titanium or cobalt-chrome) inoculated with MRSA were implanted in ewes.
  • Animals were divided into three groups: control, linezolid alone, and linezolid plus AMF.
  • Biofilm reduction, bacterial load in tissues, cytokine levels, and histopathology were assessed at 5 and 21 days post-implantation.

Main Results:

  • The AMF-linezolid combination significantly reduced biofilm on both titanium and cobalt-chrome implants.
  • Substantial reductions in bacterial load were observed in surrounding tissues and bones.
  • Combination therapy led to improved inflammatory responses, reduced necrosis, and decreased bacterial presence.

Conclusions:

  • Combining AMF with antibiotics is effective in reducing biofilm-associated infections on metal implants.
  • AMF demonstrates potential as a non-invasive therapeutic modality for prosthetic joint infections.
  • Numerical simulations confirmed targeted heating, supporting the mechanism of action.